We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
2576
DELISTED
Meridian Bioscience Inc
VIVO
| $726K | ﹤0.01% |
+27,962
| New | +$665K |
|
2577
Dana Inc
DAN
$2.88B
| $725K | ﹤0.01% |
41,265
-270,538
| -87% | -$5.53M |
|
|
KWAC
2578
DELISTED
Kingswood Acquisition Corp.
KWAC
| $725K | ﹤0.01% |
71,113
| – | – |
|
2579
Amcor
AMCR
$21.2B
| $723K | ﹤0.01% |
12,763
+12,232
| +2,304% | +$714K |
|
|
K
2580
DELISTED
Kellanova
K
| $722K | ﹤0.01% |
11,916
-33,934
| -74% | -$2.04M |
|
2581
Immunocore
IMCR
$1.7B
| $721K | ﹤0.01% |
24,120
| – | – |
|
|
TCDA
2582
DELISTED
Tricida, Inc. Common Stock
TCDA
| $721K | ﹤0.01% |
+87,914
| New | +$795K |
|
2583
Weave Communications
WEAV
$553M
| $717K | ﹤0.01% |
120,231
+41,567
| +53% | +$370K |
|
2584
AppFolio
APPF
$6.62B
| $716K | ﹤0.01% |
+6,324
| New | +$728K |
|
2585
Medallion Financial
MFIN
$230M
| $716K | ﹤0.01% |
+84,282
| New | +$650K |
|
|
AFAC
2586
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
| $715K | ﹤0.01% |
+71,501
| New | +$710K |
|
|
KPLTW
2587
CALL
DELISTED
Katapult Holdings Warrant
KPLTW
| $713K | ﹤0.01% |
300,000
+100,000
| +50% | +$37.6K |
|
2588
Ribbon Communications
RBBN
$386M
| $712K | ﹤0.01% |
+230,524
| New | +$945K |
|
|
UHGWW
2589
CALL
DELISTED
United Homes Group Warrant
UHGWW
| $711K | ﹤0.01% |
72,512
| – | – |
|
|
VLN.WS
2590
CALL
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
| $711K | ﹤0.01% |
135,077
-14,923
| -10% | -$7.61K |
|
|
APPHW
2591
CALL
DELISTED
AppHarvest, Inc. Warrants
APPHW
| $711K | ﹤0.01% |
132,123
-22,877
| -15% | -$15.1K |
|
2592
iShares Select U.S. REIT ETF
ICF
$2.13B
| $710K | ﹤0.01% |
+10,000
| New | +$689K |
|
2593
First Solar
FSLR
$21.4B
| $709K | ﹤0.01% |
8,460
-119,557
| -93% | -$9.15M |
|
2594
Western Digital
WDC
$159B
| $709K | ﹤0.01% |
18,881
-104,198
| -85% | -$4.28M |
|
2595
The Joint Corp
JYNT
$119M
| $708K | ﹤0.01% |
+20,046
| New | +$927K |
|
2596
Arq
ARQ
$83.3M
| $708K | ﹤0.01% |
113,820
-82,038
| -42% | -$520K |
|
|
PLG
2597
Platinum Group Metals
PLG
$160M
| $706K | ﹤0.01% |
333,963
+129,979
| +64% | +$251K |
|
2598
MarineMax
HZO
$748M
| $705K | ﹤0.01% |
+17,525
| New | +$823K |
|
|
NREF
2599
NexPoint Real Estate Finance
NREF
$318M
| $702K | ﹤0.01% |
31,045
-73,514
| -70% | -$1.53M |
|
2600
PG&E
PCG
$39B
| $702K | ﹤0.01% |
+58,770
| New | +$695K |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.